Evidence map›Paper›PMID 40066011›Full record

ArticleFrontiers in public health2025

Evaluating the effectiveness and limitations of online health information tools in assessing the quality of medication-related content.

Adel S Alhlayl, Haitham A Alzghaibi

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Adel S AlhlaylDepartment of Continuous Education at the Executive Directorate of Training and Research Affairs, Hail Health Cluster, Hail, Saudi Arabia.
Haitham A AlzghaibiDepartment of Health Informatics, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The internet has become a primary source of information on medicines, yet the quality of this information is inconsistent. Despite the proliferation of web-based resources, limited research has specifically examined the reliability of online information on medicines. The variability in quality can be attributed to the recent shift toward digital information-seeking and the absence of specialized tools designed to assess the quality of medication-related information online. Aim: To evaluate the quality of information about Amitriptyline available on websites using three well-established, generic evaluation tools-HONcode, DISCERN, and JAMA-compared against the domain-specific Keystone action plan criteria. Methods: Adopting an evaluative research design, this study utilized the aforementioned four assessment tools to collect and analyze data. Four independent assessors were recruited to evaluate the quality of the information on selected websites. Results: A Google search using "Amitriptyline" identified 30 websites for the study sample. Reliability analysis using Cronbach's alpha, the Inter-Class Correlation coefficient, and Kendall's rank-order correlation coefficient revealed that the Keystone criteria demonstrated the highest internal consistency and reliability compared to DISCERN, HONcode, and JAMA. Conclusion: This study indicates that the Keystone action plan criteria may serve as a reliable, domain-specific tool for evaluating medicines information on websites. The results underscore the importance of specialized assessment criteria for online medication information, as they provide more consistent and accurate evaluations compared to generic tools.

Indexed as

AmitriptylineConsumer Health InformationInternetHumansReproducibility of ResultsAmitriptylineamitriptylinekeystone criteriamedication informationonline health informationreliability testingweb-based assessment tools

Identifiers

PMID40066011
PMCPMC11891361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.